Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, ...
Please provide your email address to receive an email when new articles are posted on . “If there is a clinical concern about [arteriovenous fistula] AVF maturation after surgery, a 6-week ultrasound ...
The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week's Controversies in Dialysis Access (CiDA) 15 th Anniversary Meeting, ...
Please provide your email address to receive an email when new articles are posted on . Due to successful and durable access for hemodialysis through 5 years, percutaneous fistulas can be an ...
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Avenu Medical, Inc. announced today that it has received De Novo marketing authorization from the Food and Drug Administration (FDA) to market its ...